These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 22581716

  • 21. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer.
    Leach BC, Kulbersh JS, Day TA, Cook J.
    Dermatol Surg; 2008 Apr; 34(4):483-97. PubMed ID: 18248467
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
    Veness MJ, Morgan GJ, Palme CE, Gebski V.
    Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
    [Abstract] [Full Text] [Related]

  • 24. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.
    Boscolo-Rizzo P, Da Mosto MC, Gava A, Marchiori C.
    ORL J Otorhinolaryngol Relat Spec; 2006 May; 68(4):189-94. PubMed ID: 16479145
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of skin involvement from mucosal tumors of the head and neck.
    Cole RD, McGuirt WF.
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1246-8. PubMed ID: 7576469
    [Abstract] [Full Text] [Related]

  • 26. Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread.
    Kelder W, Ebrahimi A, Forest VI, Gao K, Murali R, Clark JR.
    Ann Surg Oncol; 2012 Jan; 19(1):274-9. PubMed ID: 21826558
    [Abstract] [Full Text] [Related]

  • 27. Analysis of unknown primary carcinomas metastatic to the neck: diagnosis, treatment, and outcomes.
    Doty JM, Gossman D, Kudrimoti M, Valentino J, Arnold S, Spring PM.
    J Ky Med Assoc; 2006 Feb; 104(2):57-64. PubMed ID: 16594571
    [Abstract] [Full Text] [Related]

  • 28. Significance of clinical stage, extent of surgery and outcome in cutaneous squamous cell carcinoma of the head and neck.
    Košec A, Svetina L, Lukšić I.
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):82-8. PubMed ID: 23137734
    [Abstract] [Full Text] [Related]

  • 29. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K, Sherman W, Niedt GW, Taback B, Manolidis S, Wang A, Ratner D.
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [Abstract] [Full Text] [Related]

  • 30. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
    Kiyota N, Tahara M, Okano S, Kawashima M, Matsuura K, Onozawa Y, Nibu K, Hayashi R, Yoshimura K, Ohtsu A.
    Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR, Moore MG, Brigance JS, Gordon CA, Summerlin DJ, McDonald MW.
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [Abstract] [Full Text] [Related]

  • 36. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
    Kreppel M, Krakowezki A, Kreppel B, Drebber U, Wedemeyer I, Mauch C, Zöller JE, Scheer M.
    J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
    [Abstract] [Full Text] [Related]

  • 37. Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period.
    Eckardt A, Barth EL, Kokemueller H, Wegener G.
    Oral Oncol; 2004 Apr; 40(4):427-32. PubMed ID: 14969822
    [Abstract] [Full Text] [Related]

  • 38. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA, MaDan OP, Lentsch EJ.
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [Abstract] [Full Text] [Related]

  • 39. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
    Ljumanovic R, Langendijk JA, Hoekstra OS, Leemans CR, Castelijns JA.
    Eur J Radiol; 2006 Oct; 60(1):58-66. PubMed ID: 16829010
    [Abstract] [Full Text] [Related]

  • 40. [Identification of clinical, biological and prognostic factors in recurring squamous cell carcinoma of the head and neck].
    De Stefani A, Magnano M, Bussi M, Cravero L, Lerda W, Usai A, Cavalot A, Ragona R, Gabriele P, Valente G, Cortesina G.
    Acta Otorhinolaryngol Ital; 1997 Jun; 17(3):219-24. PubMed ID: 9489148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.